BioInvent International AB, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, announces that it has signed a manufacturing agreement with a cell therapy company based in Massachusetts, USA.
April 30, 2020
· 2 min read